维普中文期刊产品整合服务
18篇 您的检索式:作者名="CLETO S"
    题名 作者 年代 出处 被引量
1Door - to - dialysis time and daily hemodialysis in patients with leptospirosis: impact on mortality 显示文摘Andrade L Cleto S Seguro AC 2007Clin J Am SocNephrol2007,2,:1
2Rituximab and chemotherapy in primary gastric lymphoma显示文摘Aviles A Castafieda C Cleto S 2009Cancer Biother Radiopharm2009,24,1:1
3Rituximab and dose-dense chemotherapy in primary testicular lymphoma显示文摘Avilés A Nambo MJ Cleto S 2009Clin Lymphoma Myeloma2009,9,5:1
4Rituximab and chemotherapy in primary gastric lymphoma显示文摘Aviles A Castaneda C Cleto S 2009Cancer Biother Radiopharm2009,24,1:1
5Rituximab and chemotherapy in primary gastric lymphoma显示文摘Aviles A Castaneda C Cleto S 2009Cancer Biother Radiopharm2009,24,1:1
6Door-to-dialysis time and daily hemodialysis in patients with leptospirosis: impact on mortality显示文摘Andrade L Cleto S Seguro AC 2007CJASN2007,2,:1
7Swim training does not protect mice from skeletal muscle oxidative damage following a maximum exercise test显示文摘Barreto T O Cleto L S Gioda C R 2012Eur J Appl Physiol2012,112,7:1
8Rituximab and chemotherapy in primary gastric lymphoma显示文摘AVlL(E)S A CASTA(N)EDA C CLETO S 2009Cancer BiotherRadiopharm2009,24,1:1
9Door-to-dialysis time and daily hemodialysis in patients with leptospirosis:impact on mortality 显示文摘Andrade L Cleto S Seguro AC 2007Clin J Am Soc Nephrol2007,2,4:1
10Rituximab and dose chemotherapy in primary testicular lymphoma显示文摘Aviles A Nambo M Cleto S 2009Clinical Lymphoma & Myeloma2009,9,5:1
11Rituximab and chemotherapy in primary gastric lymphoma 显示文摘Avil6s A Castatleda C Cleto S 2009Cancer Biother Radiopharm2009,24,1:1
12Rituximab and dosedense chemotherapy in primary testicular lymphoma 显示文摘Aviles A Nambo M J Cleto S 2009Clin Lymphoma Myeloma2009,,5:1
13Rituximab and chemother- apy in primary gastric lymphoma 显示文摘Avil6s A Castafieda C Cleto S 2009Cancer Biother Radiopharm2009,24,1:1
14Door-to-dialysis time and daily hemodialysis in patients with leptospirosis:impact on mortality显示文摘Andrade L Cleto S Seguro A 2007Clin J Am Soc Nephrol2007,2,4:1
15Rituximab and chemotherapy in primary gastric lymphoma 显示文摘Aviles A Castafieda C Cleto S 2009Cancer Biother Radiopharm2009,24,1:1
16Chemotherapy plus interferon-alpha2b versus chemotherapy in the treatment of follicular lymphoma显示文摘Neri N Aviles A Cleto S 2001J Hematother Stem Cell Res2001,10,5:1
17Rituximab and chemotherapy in primary gastric lymphoma显示文摘Aviles A Castaneda C Cleto S 2009Cancer Biother Radiopharm2009,240,:1
18Subcutaneous fatty acid composition of steers finished as weanlings or yearlings with and without growth promotants显示文摘Background: The current study evaluated the subcutaneous fatty acid(FA) composition of calf- and yearling-fed stee with or without growth promoting implants. Crossbred steers(n = 112; 267 ± 5.0 kg) of the same contemporary group were allocated to one of four production system and implant strategy based treatments in a completely randomized design with a 2 × 2 factorial arrangement of treatments.Results: There were no interactions(P > 0.05) between production systems and growth promoting implants for the total and individual subcutaneous FA. Yearling as opposed to calf finishing reduced(P < 0.05) subcutaneous proportions of C20:3n-6, trans(t)12-18:1, C14:0, several minor cis-monounsaturated FA(c-MUFA; c9-14:1, c11-16:1,c11-18:1, c12-18:1, c13-18:1, c9-20:1 and c11-20:1), and increased(P < 0.05) subcutaneous proportions of t11c15-18:2,total and individual branched-chain FA. Subcutaneous fat from steers implanted with growth promotants had higher(P < 0.05) proportions of total polyunsaturated FA(PUFA), total n-6 PUFA, C18:2n-6 and individual t-18:1isomers(t6 to t10) compared to non-implanted steers.Conclusions: Overall, current findings show that production systems and growth promotants led to only minor differences in subcutaneous FA composition of beef steers.Cletos Mapiye Tyler D Turner John A Basarab Vern S Baron Jennifer L Aalhus Michael ER Dugan 2014Journal of Animal Science and Biotechnology2014,5,1:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费